Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: Risk assessment vs. Risk aversion

1. Zannad, F.
2. Stough, W.G.
3. Lipicky, R.J.
4. Tamargo, J.
5. Bakris, G.L.
6. Borer, J.S.
7. De Los Angeles Alonso García, M.
8. Hadjadj, S.
9. Koenig, W.
10. Kupfer, S.
11. McCullough, P.A.
12. Mosenzon, O.
13. Pocock, S.
14. Scheen, A.J.
15. Sourij, H.
16. Van der Schueren, B.
17. Stahre, C.
18. White, W.B.
19. Calvo, G.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/EHJCVP/PVW007 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus